NEW YORK, May 23 (Reuters) – Allergan Plc Chief
Executive Brent Saunders said on Monday the company expects to
close the $40.5 billion sale of its generic medicines portfolio
to Teva Pharmaceutical…
The post UPDATE 1-Allergan CEO says company is “weeks away” from closing Teva deal appeared first on NASDAQ.